CLIA lab

CLIA 05D2216122: Royal Pharmacy Drugs

Glendale, CA. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 05D2216122 belongs to Royal Pharmacy Drugs in Glendale, CA.

Certificate of Waiver, effective March 9, 2025, expires March 8, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
March 9, 2025
Certificate expiration
March 8, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
March 9, 2021
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
05D2216122
Lab name
Royal Pharmacy Drugs
Address
1101 1/2 W Glenoaks Blvd, Glendale, CA 91202
Phone
(818) 484-7484
Fax
(818) 484-7434

Annual test volume the lab reported

Waived tests
1,500

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Other labs in Glendale, CA

Related

Questions

What is the CLIA number for Royal Pharmacy Drugs in Glendale?

05D2216122, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Royal Pharmacy Drugs hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 05D2216122 expire?

The CMS file lists March 8, 2027 as the certificate expiration date; the certificate took effect March 9, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.